PATENT CLAIM ANALYSIS

Application Number: 15910745
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "451000"]

Abstract:
Provided herein are compositions containing compounds, or pharmaceutically acceptable salts, that metabolize to monomethyl fumarate with certain pharmacokinetic parameters and methods for treating, prophylaxis, or amelioration of neurodegenerative diseases including multiple sclerosis using such compositions in a subject, wherein if the compositions contain dimethyl fumarate, the total amount of dimethyl fumarate in the compositions ranges from about 43% w/w to about 95% w/w.

Claim (Index 25):
The capsule of  claim 23 , wherein the amount of dimethyl fumarate in the microtablets is about 60% w/w to about 70% w/w and the capsule contains about 35 to about 55 microtablets.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.38462
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15686352', '15125612', '15248506', '15299535', '15582913']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7350508843497344
- 35 USC 102 Novelty (BERT): 0.5069067185498222
- Combined Prediction Score: 0.7122364677697433
- Mean Citation Score: 226.95391400000003
- Max Citation Score: 236.01488
- Similarity Product: 150.27360821119308

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test